bpc-157 safety human clinical data and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded bpc-157 human clinical trials evidence
Description
The standard approach uses 0.25 to 0.5 mg daily via subcutaneous injection near the medial epicondyle for 4 to 8 weeks
Once this has been completed we will break for a short time before starting live models
2 Grip Strength and Exercise Endurance in Aged Mice Dimet-Wiley et al., Scientific Reports (2024) This study compared 5-Amino-1MQ treatment, voluntary wheel-running exercise (PoWeR), and combined treatment in aged C57BL/6J mice
Some common signs include persistent fatigue or weakness, trouble with balance, and that annoying pins and needles feeling in your hands or feet
Typically, treatment will be once each week for 2-6 weeks
Only bacteriostatic water from reputable sources ensures safety
